Cited by 1,273CRISPR and Genetic EngineeringRNA regulation and diseaseRNA Interference and Gene Delivery

The DOI matches its Crossref record; 81 of the 82 references it cites were found in a registry or an index.

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Open access

Zhang, Xiao-Hui, Tee, Louis Y, Wang, Xiao-Gang, Huang, Qun-Shan, Yang, Shi-Hua·2015·Molecular Therapy - Nucleic Acids

DOI 10.1038/mtna.2015.37PMC PMC4877446

Open this paper in CoChat — free account Open PDF

Abstract

CRISPR/Cas9 is a versatile genome-editing technology that is widely used for studying the functionality of genetic elements, creating genetically modified organisms as well as preclinical research of genetic disorders. However, the high frequency of off-target activity (≥50%)-RGEN (RNA-guided endonuclease)-induced mutations at sites other than the intended on-target site-is one major concern, especially for therapeutic and clinical applications. Here, we review the basic mechanisms underlying off-target cutting in the CRISPR/Cas9 system, methods for detecting off-target mutations, and strategies for minimizing off-target cleavage. The improvement off-target specificity in the CRISPR/Cas9 system will provide solid genotype-phenotype correlations, and thus enable faithful interpretation of genome-editing data, which will certainly facilitate the basic and clinical application of this technology.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1038/mtna.2015.37

Cites

81 of 81 references verified0 citation errors · 0 not checkable

Statistics

Figure 1 Base preferences for CRISPR/Cas9 system. Cas9 protein is shown in orange. PAM and seed sequences are shown in red. Base preferences are shown in blue. Scissors indicate cleavage sites. The single-letter DNA code is used (N=A, T, C, G; R=G or A).CC BY-NC-SA · PubMed Central

Figure 2 Methods for optimal CRISPR/Cas9 system for biomedical and clinical application. (a) Double nicking by RNA-Guided CRISPR Cas9 for enhanced genome-editing speciﬁcity. Cas9 protein is shown in orange. Scissors indicate cleavage sites. (b) Fusion of catalytically inactive Cas9 to Fok I nuclease. (c) Delivery of Cas9 protein. cPP, cell-penetrating peptide. The single-letter codes for amino acids are used. C, cysteine; G, glycine; R, arginine; L, leucine. His, Histidine tag; HA, hemagglutinin tag; Mal, maleimide. (d) Alternative PAMs for CIRSPR/Cas9 system. (e) SgRNA design—CRISPR/Cas9 design tools. (f) Method of off-target detection-Degenome-seq. IGV, Integrative Genomics Viewer; WGS, whole-genome sequencing; WT, wild type.CC BY-NC-SA · PubMed Central

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

A Programmable Dual-RNA–Guided DNA Endonuclease in Adaptive Bacterial Immunity
Jinek, M., Chylinski, K., Fonfara, I., Hauer, M., Doudna, J. A., & Charpentier, E. (2012) · Science · doi:10.1126/science.1225829 · Cited by 17,116
Multiplex Genome Engineering Using CRISPR/Cas Systems
Cong, L., Ran, F. A., Cox, D., Lin, S., Barretto, R., Habib, N., Hsu, P. D., Wu, X., Jiang, W., Marraffini, L. A., et al. (2013) · Science · doi:10.1126/science.1231143 · Cited by 15,339
Genome engineering using the CRISPR-Cas9 system
Ran, F. A., Hsu, P. D., Wright, J., Agarwala, V., Scott, D. A., & Zhang, F. (2013) · Nature Protocols · doi:10.1038/nprot.2013.143 · Cited by 11,133
RNA-Guided Human Genome Engineering via Cas9
Mali, P., Yang, L., Esvelt, K. M., Aach, J., Guell, M., DiCarlo, J. E., Norville, J. E., & Church, G. M. (2013) · Science · doi:10.1126/science.1232033 · Cited by 9,210
The new frontier of genome engineering with CRISPR-Cas9
Doudna, J. A., & Charpentier, E. (2014) · Science · doi:10.1126/science.1258096 · Cited by 7,062
Development and Applications of CRISPR-Cas9 for Genome Engineering
Hsu, P. D., Lander, E. S., & Zhang, F. (2014) · Cell · doi:10.1016/j.cell.2014.05.010 · Cited by 5,762
Improved vectors and genome-wide libraries for CRISPR screening
Sanjana, N. E., Shalem, O., & Zhang, F. (2014) · Nature Methods · doi:10.1038/nmeth.3047 · Cited by 5,239
Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
Qi, L. S., Larson, M. H., Gilbert, L. A., Doudna, J. A., Weissman, J. S., Arkin, A. P., & Lim, W. A. (2013) · Cell · doi:10.1016/j.cell.2013.02.022 · Cited by 5,016
Cpf1 Is a Single RNA-Guided Endonuclease of a Class 2 CRISPR-Cas System
Zetsche, B., Gootenberg, J. S., Abudayyeh, O. O., Slaymaker, I. M., Makarova, K. S., Essletzbichler, P., Volz, S. E., Joung, J., van der Oost, J., Regev, A., et al. (2015) · Cell · doi:10.1016/j.cell.2015.09.038 · Cited by 4,761
DNA targeting specificity of RNA-guided Cas9 nucleases
Hsu, P. D., Scott, D. A., Weinstein, J. A., Ran, F. A., Konermann, S., Agarwala, V., Li, Y., Fine, E. J., Wu, X., Shalem, O., et al. (2013) · Nature Biotechnology · doi:10.1038/nbt.2647 · Cited by 4,741

Show all 82 references

Sorted by citations

Items 701–800 of 1,000

New developments in biotechnology applied to animals: An assessment of the adequacy and sufficiency of current EFSA guidance for animal risk assessment
(GMO), E. P. O. G. M. O., Casacuberta, J., Barro, F., Braeuning, A., de Maagd, R. A., Epstein, M. M., Frenzel, T., Gallois, J., Koning, F., Messéan, A., et al. (2025) · EFSA Journal · doi:10.2903/j.efsa.2025.9566 · Cited by 9
Assessing off-target effects in CRISPR/Cas9: challenges and strategies for precision DNA editing
Basit, A., Zhu, J., & Zheng, W. (2026) · Archives of Microbiology · doi:10.1007/s00203-025-04687-4 · Cited by 11
Perspective on the use of synthetic biology in rudimentary food fermentations
Vale, A. D. S., Pereira, G. V. D. M., Martins‐Santana, L., Neto, D. P. D. C., Colonia, B. S. O., Thomaz‐Soccol, V., Maske, B. L., & Soccol, C. R. (2022) · Systems Microbiology and Biomanufacturing · doi:10.1007/s43393-022-00131-6 · Cited by 9
What did CRISPR-Cas9 accomplish in its first 10 years?
Khlidj, Y. (2023) · Biochemia Medica · doi:10.11613/bm.2023.030601 · Cited by 9
Expanding the genome editing toolbox ofSaccharomyces cerevisiaewith the endonucleaseErCas12a
Bennis, N. X., Anderson, J. P., Kok, S. M. C., & Daran, J.-M. G. (2023) · FEMS Yeast Research · doi:10.1093/femsyr/foad043 · Cited by 9
Photoactivatable Engineering of CRISPR/Cas9‐Inducible DNAzyme Probe for In Situ Imaging of Nuclear Zinc Ions
Liu, R., Jiang, D., Yun, Y., Feng, Z., Zheng, F., Xiang, Y., Fan, H., & Zhang, J. (2024) · Angewandte Chemie · doi:10.1002/ange.202315536 · Cited by 9
Gene editing in small and large animals for translational medicine: a review
Mariano, C. G., Souza, V. C. D. O., & Ambrósio, C. E. (2024) · Animal Reproduction · doi:10.1590/1984-3143-ar2023-0089 · Cited by 9
Quantifying allele-specific CRISPR editing activity with CRISPECTOR2.0
Assa, G., Kalter, N., Rosenberg, M., Beck, A., Markovich, O., Gontmakher, T., Hendel, A., & Yakhini, Z. (2024) · Nucleic Acids Research · doi:10.1093/nar/gkae651 · Cited by 9
Structural variation of types IV-A1- and IV-A3-mediated CRISPR interference
Čepaitė, R., Klein, N., Mikšys, A., Camara-Wilpert, S., Ragožius, V., Benz, F., Skorupskaitė, A., Becker, H., Žvejytė, G., Steube, N., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-53778-1 · Cited by 9
Strategic base modifications refine RNA function and reduce CRISPR–Cas9 off-targets
Zhang, K., Shen, W. H., Zhao, Y., Xu, X., Liu, X., Qi, Q., Huang, S., Tian, T., & Zhou, X. (2025) · Nucleic Acids Research · doi:10.1093/nar/gkaf082 · Cited by 9
Photoactivatable CRISPR/Cas9 lateral flow strip platform for one-pot rapid detection of squamous cell carcinoma antigen DNA in blood
Yang, Z., Guo, B., Hu, C., Tang, C., Shen, Y., Zhang, B., & Wang, F. (2025) · Sensors and Actuators B Chemical · doi:10.1016/j.snb.2025.137607 · Cited by 9
Applications of genome editing on laboratory animals
Galichet, C., & Lovell-Badge, R. H. (2021) · Laboratory Animals · doi:10.1177/0023677221993141 · Cited by 9
Cas9 conjugate complex delivering donor DNA for efficient gene editing by homology-directed repair
Kang, Y. K., Lee, J. H., Im, S. H., Lee, J. H., Jeong, J., Kim, D. K., Yang, S. Y., Jung, K., Kim, S., & Chung, H. J. (2021) · Journal of Industrial and Engineering Chemistry · doi:10.1016/j.jiec.2021.07.009 · Cited by 9
Self-citation
Single nucleotide substitutions effectively block Cas9 and allow for scarless genome editing in Caenorhabditis elegans
Medley, J. C., Hebbar, S., Sydzyik, J. T., & Zinovyeva, A. (2021) · Genetics · doi:10.1093/genetics/iyab199 · Cited by 9
“Bind, cleave and leave”: multiple turnover catalysis of RNA cleavage by bulge–loop inducing supramolecular conjugates
Amirloo, B., Staroseletz, Y., Yousaf, S., Clarke, D. J., Brown, T. P., Aojula, H. S., Аркадьевна, З. М., & Bichenkova, E. V. (2021) · Nucleic Acids Research · doi:10.1093/nar/gkab1273 · Cited by 9
CRISPR-Cas Assisted Shotgun Mutagenesis Method for Evolutionary Genome Engineering
Zhao, M., Gao, M., Xiong, L., Liu, Y., Tao, X., Gao, B., Liu, M., Wang, F., & Wei, D. (2022) · ACS Synthetic Biology · doi:10.1021/acssynbio.2c00112 · Cited by 9
At the Heart of Genome Editing and Cardiovascular Diseases
Hernández‐Benítez, R., Martinez, L. M., Lajara, J., Magistretti, P. J., Montserrat, N., & Belmonte, J. C. I. (2018) · Circulation Research · doi:10.1161/circresaha.118.312676 · Cited by 9
Potential in vitro and ex vivo targeting of bZIP53 involved in stress response and seed maturation in Arabidopsis thaliana by five designed peptide inhibitors
Jain, P., Shah, K., & Rishi, V. (2018) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2018.09.007 · Cited by 9
An overview of applications of CRISPR-Cas technologies in biomedical engineering
Jamehdor, S., Zaboli, K. A., Naserian, S., Thekkiniath, J., Omidy, H. A., Teimoori, A., Johari, B., Taromchi, A. H., Sasano, Y., & Kaboli, S. (2020) · Folia Histochemica et Cytobiologica · doi:10.5603/fhc.a2020.0023 · Cited by 9
Development of a pyrF-based counterselectable system for targeted gene deletion in Streptomyces rimosus
Yang, Y., Sun, Q., Liu, Y., Yin, H., Yang, W., Wang, Y., Liu, Y., Li, Y., Pang, S., Liu, W., et al. (2021) · Journal of Zhejiang University SCIENCE B · doi:10.1631/jzus.b2000606 · Cited by 9
Self-citation
CRISPR/Cas9-mediated in vivo gene editing reveals that neuronal 5-HT1A receptors in the dorsal raphe nucleus contribute to body temperature regulation in mice
Nishitani, N., Ohmura, Y., Nagayasu, K., Shibui, N., Kaneko, S., Ohashi, A., Yoshida, T., Yamanaka, A., & Yoshioka, M. (2019) · Brain Research · doi:10.1016/j.brainres.2019.06.009 · Cited by 10
GEARBOCS: An Adeno Associated Virus Tool for In Vivo Gene Editing in AstrocytesPreprint
Bindu, D. S., Savage, J. T., Brose, N., Bradley, L., Dimond, K., Tan, C. X., & Eroğlu, Ç. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.01.17.524433 · Cited by 10
A Comparison of Inducible Gene Expression Platforms: Implications for Recombinant Adeno-Associated Virus (rAAV) Vector-Mediated Ocular Gene Therapy
Lipinski, D. M. (2019) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-030-27378-1_13 · Cited by 8
Developing a Versatile Arsenal: Novel Antimicrobials as Offensive Tools Against Pathogenic Bacteria
Ma, J., & Lu, Z. (2025) · Microorganisms · doi:10.3390/microorganisms13010172 · Cited by 8
Harnessing CRISPR/Cas systems for tailored therapeutic interventions in molecular medicine: Advancements in precision medicine and enhanced patient care
Kumar, A. V., Garg, V. K., & Buttar, H. S. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-22300-6.00044-9 · Cited by 10
CRISPR-Cas: From bacterial immunity to precision genome engineering
Abbas, S., Saeed, A., Bibi, M., Perveen, S., & Masood, N. (2025) · Gene Reports · doi:10.1016/j.genrep.2025.102296 · Cited by 8
Emerging Therapeutic Strategies for HPV-Related Cancers: From Gene Editing to Precision Oncology
Çakır, M. O., Kayhan, G., Yilmaz, B., Özdoğan, M., & Ashrafi, G. H. (2025) · Current Issues in Molecular Biology · doi:10.3390/cimb47090759 · Cited by 8
Engineered Lactiplantibacillus plantarum and Levilactobacillus brevis utilizing ribonucleoprotein-mediated editing for inactivation of hemolysin gene
Kim, H. J., Kwon, M. Y., Song, S., Cheon, S. W., & Kim, H. J. (2025) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04598-y · Cited by 8
CRISPR-Cas9-mediated therapeutics: Current clinical trials and therapy approval landscape to treat human diseases
Chakraborty, C., Bhattacharya, M., Das, A., Agoramoorthy, G., & Lee, S.-S. (2026) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2026.102859 · Cited by 8
Challenges and Future Prospects of CRISPR Technology
Khan, Z., Khan, S. H., & Ahmad, A. (2021) · Springer eBooks · doi:10.1007/978-981-16-6305-5_10 · Cited by 9
CRISPR-Cas9 based non-viral approaches in nanoparticle elicited therapeutic delivery
Rani, V., & Prabhu, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103737 · Cited by 8
“iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives”
Roman, G., Stavik, B., Lauritzen, K. H., Sandset, P. M., Harrison, S. P., Sullivan, G. J., & Chollet, M. E. (2023) · Frontiers in Physiology · doi:10.3389/fphys.2023.1094249 · Cited by 8
Genetic and Molecular Quality Control of Genetically Engineered Mice
Lintott, L. G., & Nutter, L. M. J. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2990-1_3 · Cited by 8
Release Assays and Potency Assays for CAR T-Cell Interventions
Dias, J., Cadiñanos-Garai, A., & Roddie, C. (2023) · Advances in experimental medicine and biology · doi:10.1007/978-3-031-30040-0_8 · Cited by 10
Efficient multiple gene knockout in Colletotrichum higginsianum via CRISPR/C as9 ribonucleoprotein and URA3 ‐based marker recycling
Yonehara, K., Kumakura, N., Motoyama, T., Ishihama, N., Dallery, J., O’Connell, R. J., & Shirasu, K. (2023) · Molecular Plant Pathology · doi:10.1111/mpp.13378 · Cited by 8
Recent advances in genome engineering by CRISPR technology
Lee, Y., Oh, Y., & Lee, S. H. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0157 · Cited by 10
Coupling High-Throughput and Targeted Screening for Identification of Nonobvious Metabolic Engineering Targets
Babaei, M., Thomsen, P. T., Pastor, M. C., Jensen, M. K., & Borodina, I. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00396 · Cited by 8
Gene therapy strategies for RAG1 deficiency: Challenges and breakthroughs
Gilioli, G., Lankester, A. C., de Kivit, S., Staal, F. J. T., & de Bruin, L. M. O. (2024) · Immunology Letters · doi:10.1016/j.imlet.2024.106931 · Cited by 8
Strategies for programmable manipulation of alternative splicing
Schmok, J. C., & Yeo, G. W.-M. (2024) · Current Opinion in Genetics & Development · doi:10.1016/j.gde.2024.102272 · Cited by 8
Engineering tripartite gene editing machinery for highly efficient non-viral targeted genome integration
Nam, H., Xie, K., Majumdar, I., Wang, J., Yang, S., Starzyk, J., Lee, D., Shan, R., Li, J., & Wu, H. (2025) · Nature Communications · doi:10.1038/s41467-025-59790-3 · Cited by 8
Self-citation
Genome Editing of the CYP1A1 Locus in iPSCs as a Platform to Map AHR Expression throughout Human Development
Smith, B. W., Stanford, E. A., Sherr, D. H., & Murphy, G. J. (2016) · Stem Cells International · doi:10.1155/2016/2574152 · Cited by 8
CRISPR/Cas9-mediated gene knockout in human adipose stem/progenitor cells
Mandl, M., Ritthammer, H., Ejaz, A., Wagner, S., Hatzmann, F. M., Baumgarten, S., Viertler, H. P., Zwierzina, M., Mattesich, M., Schiller, V., et al. (2020) · Adipocyte · doi:10.1080/21623945.2020.1834230 · Cited by 8
Can genetic engineering-based methods for gene function identification be eclipsed by genome editing in plants? A comparison of methodologies
Amritha, P. P., & Shah, J. M. (2021) · Molecular Genetics and Genomics · doi:10.1007/s00438-021-01769-y · Cited by 8
Unresolved Issues in RNA Therapeutics in Vascular Diseases With a Focus on Aneurysm Disease
Schellinger, I. N., Dannert, A., Mattern, K., Raaz, U., & Tsao, P. S. (2021) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2021.571076 · Cited by 8
Challenges and Prospects for Designer T and NK Cells in Glioblastoma Immunotherapy
Arnesen, V. S., Navarro, A. G., & Chekenya, M. (2021) · Cancers · doi:10.3390/cancers13194986 · Cited by 8
Detection of pks Island mRNAs Using Toehold Sensors in Escherichia coli
Heo, T., Kang, H., Choi, S., & Kim, J. (2021) · Life · doi:10.3390/life11111280 · Cited by 8
Elucidating miRNA Function in Cancer Biology via the Molecular Genetics’ Toolbox
Azlan, A., Rajasegaran, Y., Khor, K. Z., Rosli, A. A., Yik, M. Y., Yusoff, N. M., Heidenreich, O. T., & Moses, E. J. (2022) · Biomedicines · doi:10.3390/biomedicines10040915 · Cited by 8
Genetic advancements in obesity management and CRISPR–Cas9-based gene editing system
Jayachandran, M., Fei, Z., & Qu, S. (2022) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-022-04518-w · Cited by 10
Novel and Engineered Type II CRISPR Systems from Uncultivated Microbes with Broad Genome Editing Capability
Alexander, L. M., Goltsman, D. S. A., Liu, J., Lin, J., Temoche-Diaz, M. M., Laperriere, S. M., Neerincx, A., Bednarski, C., Knyphausen, P., Cohnen, A., et al. (2023) · The CRISPR Journal · doi:10.1089/crispr.2022.0090 · Cited by 10
Pathway-driven analysis of synthetic lethal interactions in cancer using perturbation screens
Karimpour, M., Totonchi, M., Behmanesh, M., & Montazeri, H. (2023) · Life Science Alliance · doi:10.26508/lsa.202302268 · Cited by 8
Application of CRISPR Tools for Variant Interpretation and Disease Modeling in Inherited Retinal Dystrophies
Fuster‐García, C., García‐Bohórquez, B., Rodríguez‐Muñoz, A., Millán, J. M., & García‐García, G. (2020) · Genes · doi:10.3390/genes11050473 · Cited by 10
Will CRISPR-Cas9 Have Cards to Play Against Cancer? An Update on its Applications
Senthilathiban, D. P., Kuduvalli, S. S., & Anitha, T. S. (2021) · Molecular Biotechnology · doi:10.1007/s12033-020-00289-1 · Cited by 8
Attitudes of Indonesian Medical Doctors and Medical Students Toward Genome Editing
Izzah, S. N., Setyanto, D., Hasanatuludhhiyah, N., Indiastuti, D. N., Nasution, M. Z., & d’Arqom, A. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s303881 · Cited by 8
Breaking Through the Bottleneck: Krogh's Principle in Behavioral Neuroendocrinology and the Potential of Gene Editing
Jackson, L. R., Lopez, M. S., & Alward, B. A. (2023) · Integrative and Comparative Biology · doi:10.1093/icb/icad068 · Cited by 8
Advances in CRISPR/Cas9 Technology for in Vivo Translation
Çiçek, Y. A., Luther, D. C., Kretzmann, J. A., & Rotello, V. M. (2019) · Biological and Pharmaceutical Bulletin · doi:10.1248/bpb.b18-00811 · Cited by 8
Genome-wide siRNA screen of genes regulating the LPS-induced NF-κB and TNF-α responses in mouse macrophages
Li, N., Katz, S., Dutta, B., Benet, Z. L., Sun, J., & Fraser, I. D. C. (2017) · Scientific Data · doi:10.1038/sdata.2017.8 · Cited by 9
Efficient strategies to detect genome editing and integrity in CRISPR-Cas9 engineered ESCsPreprint
Gehre, M., Buccitelli, C., Diaz, N. S., Korbel, J. O., & Noh, K. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/635151 · Cited by 8
A machine learning approach predicts essential genes and pharmacological targets in cancerPreprint
Gilvary, C. M., Madhukar, N. S., Gayvert, K. M., Foronda, M., Perez, A. R., Leslie, C. S., Dow, L. E., Pandey, G. S., & Elemento, O. (2019) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/692277 · Cited by 8
Applications of CRISPR technologies to the development of gene and cell therapy
Park, C.-S., Habib, O., Lee, Y.-S., & Hur, J. K. (2024) · BMB Reports · doi:10.5483/bmbrep.2023-0221 · Cited by 9
Enhancing tiny millets through genome editing: current status and future prospects
Weldemichael, M. Y., & Gebremedhn, H. M. (2025) · Molecular Genetics and Genomics · doi:10.1007/s00438-025-02231-z · Cited by 7
Genome Editing in Medicine: A Scoping Review of Ethical, Bioethical, and Medico-Legal Implications
Gibelli, F., Ricci, G., & Bailo, P. (2025) · The Journal of Law Medicine & Ethics · doi:10.1017/jme.2025.48 · Cited by 8
Challenges in lentiviral vector production: retro-transduction of producer cell lines
Klimpel, M., Obert, C., Terrão, M. C., Singh, P., Wei, H., Chen, C., Gille, A., Wissing, S., & Laux, H. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1569298 · Cited by 8
Advances in Precision Therapeutics and Gene Therapy Applications for Retinal Diseases: Impact and Future Directions
AlEissa, M. M., Alhawsawi, A. A., Alonazi, R. H., Magharbil, E., Aljahdali, A., ALBalawi, H. B., Alali, N. M., Hameed, S., Abu‐Amero, K. K., & Magliyah, M. (2025) · Genes · doi:10.3390/genes16070847 · Cited by 7
CRISPR tools for T cells: targeting the genome, epigenome, and transcriptome
Wachsmann, T. L. A., & Qi, L. S. (2025) · Trends in cancer · doi:10.1016/j.trecan.2025.08.001 · Cited by 8
Microfluidic electroporation for drug and gene delivery: Driving innovation from single-cell precision to high-throughput preclinical and therapeutic platforms
Liu, C. J. S., Wang, S.-B., Su, P.-Y., Hsieh, Y.-P., & Wang, H.-Y. A. (2026) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2026.115851 · Cited by 7
Harnessing artificial intelligence in plant breeding: innovations in digital phenotyping and breeding methodologies
Aggarwal, N., Rathore, M., Jan, F., Sharma, D., Kumar, S., Thudi, M., Jighly, A., Varshney, R. K., & Mir, R. R. (2026) · Theoretical and Applied Genetics · doi:10.1007/s00122-026-05293-8 · Cited by 8
CRISPR-Cas9 and Its Therapeutic Applications for Retinal Diseases
Lin, W. V., Stout, J. T., & Weng, C. Y. (2018) · International Ophthalmology Clinics · doi:10.1097/iio.0000000000000252 · Cited by 7
Comparative analysis of genome editing systems, Cas9 and BE3, in silkworms
Liu, Y., Li, Y., Liang, Y., Wang, T., Yang, C., Ma, S., & Xia, Q. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.04.170 · Cited by 7
DESIGNING gRNAs TARGETING OIL PALM PHYTOENE DESATURASE (EgPDS) GENE AND CONSTRUCTION OF VECTORS FOR OIL PALM CRISPR/CAS9 STUDY
Norfaezah, J. (2022) · Journal of Oil Palm Research · doi:10.21894/jopr.2022.0032 · Cited by 7
Immunogenicity of Therapeutic Biological Modalities - Lessons from Hemophilia A Therapies
Nguyen, N. H., Jarvi, N. L., & Balu‐Iyer, S. V. (2023) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2023.05.014 · Cited by 7
Efficient Genome Editing in Most Staphylococcus aureus by Using the Restriction-Modification System Silent CRISPR-Cas9 Toolkit
Yang, P., Yang, J., Ting, L., Liu, Q., Yin, Y., Chen, D., & Yang, S. (2023) · ACS Synthetic Biology · doi:10.1021/acssynbio.3c00339 · Cited by 7
Self-citation
Effect of the Phosphoryl Guanidine Modification in Chimeric DNA–RNA crRNAs on the Activity of the CRISPR-Cas9 System In Vitro
Prokhorova, D. V., Kupryushkin, M. S., Zhukov, S. A., Zharkov, T. D., Dovydenko, I. S., Yakovleva, K. I., Pereverzev, I. M., Matveeva, A. M., Pyshnyi, D. V., & Stepanov, G. A. (2024) · ACS Chemical Biology · doi:10.1021/acschembio.4c00147 · Cited by 7
CRISPR technology in human diseases
Feng, Q., Li, Q., Zhou, H., Wang, Z., Lin, C., Jiang, Z., Liu, T., & Wang, D. (2024) · MedComm · doi:10.1002/mco2.672 · Cited by 8
Targeting the UCP1-dependent thermogenesis pathway with CRISPR/Cas9: a new approach to obesity management
Karami, E., Rostamkhani, F., Abdollahi, M., & Ahmadifard, M. (2025) · Current Research in Biotechnology · doi:10.1016/j.crbiot.2025.100295 · Cited by 7
Revolutionising cancer intervention: the repercussions of CAR-T cell therapy on modern oncology practices
Kamli, H. M., & Khan, N. U. (2025) · Medical Oncology · doi:10.1007/s12032-025-02783-5 · Cited by 7
CRISPR-Cas9; an efficient tool for precise plant genome editing
Islam, W. (2018) · Molecular and Cellular Probes · doi:10.1016/j.mcp.2018.03.006 · Cited by 7
A protocol for custom CRISPR Cas9 donor vector construction to truncate genes in mammalian cells using pcDNA3 backbone
Vázquez, N., Sanchez, L., Marks, R., Martinez, E., Fanniel, V., Lopez, A., Salinas, A., Flores, I., Hirschmann, J., Gilkerson, R., et al. (2018) · BMC Molecular Biology · doi:10.1186/s12867-018-0105-8 · Cited by 7
A novel bioluminescent herpes simplex virus 1 for in vivo monitoring of herpes simplex encephalitis
Uyar, O., Plante, P.-L., Piret, J., Venable, M.-C., Carbonneau, J., Corbeil, J., & Boivin, G. (2021) · Scientific Reports · doi:10.1038/s41598-021-98047-z · Cited by 7
Designing libraries for pooled CRISPR functional screens of long noncoding RNAs
Pulido-Quetglas, C., & Johnson, R. (2021) · Mammalian Genome · doi:10.1007/s00335-021-09918-9 · Cited by 7
Functional Analysis of the C-5 Sterol Desaturase PcErg3 in the Sterol Auxotrophic Oomycete Pathogen Phytophthora capsici
Wang, W., Cui, T., Zhang, F., Xue, Z., Zhang, B., & Liu, X. (2022) · Frontiers in Microbiology · doi:10.3389/fmicb.2022.811132 · Cited by 7
Addressing Conflicts of Interest and Conflicts of Commitment in Public Advocacy and Policy Making on CRISPR/Cas-Based Human Genome Editing
Christian, A. (2022) · Frontiers in Research Metrics and Analytics · doi:10.3389/frma.2022.775336 · Cited by 7
Nanoparticle-based CRISPR/Cas Delivery: An Emerging Tactic for Cancer Therapy
Dilnawaz, F., & Acharya, S. (2022) · Current Medicinal Chemistry · doi:10.2174/0929867329666221006112615 · Cited by 7
Herpetin Promotes Bone Marrow Mesenchymal Stem Cells to Alleviate Carbon Tetrachloride-Induced Acute Liver Injury in Mice
Ding, Y., Tan, R., Gu, J., & Gong, P. (2023) · Molecules · doi:10.3390/molecules28093842 · Cited by 7
Study of Photochemical Cytosine to Uracil Transition via Ultrafast Photo-Cross-Linking Using Vinylcarbazole Derivatives in Duplex DNA
Sethi, S., Nakamura, S., & Fujimoto, K. (2018) · Molecules · doi:10.3390/molecules23040828 · Cited by 7
Attenuation of Inherited and Acquired Retinal Degeneration Progression with Gene-based Techniques
Cho, G. Y., Bolo, K. A., Park, K. S., Sengillo, J. D., & Tsang, S. H. (2018) · Molecular Diagnosis & Therapy · doi:10.1007/s40291-018-0377-1 · Cited by 8
Analysis of Single Nucleotide Variants in CRISPR-Cas9 Edited Zebrafish Exomes Shows No Evidence of Off-Target Inflation
Mooney, M. R., Davis, E. E., & Katsanis, N. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00949 · Cited by 7
A novel GNAS -mutated human induced pluripotent stem cell model for understanding GNAS -mutated tumors
Watanabe, K., Nakamura, T., Onodera, S., Saito, A., Shibahara, T., & Azuma, T. (2020) · Tumor Biology · doi:10.1177/1010428320962588 · Cited by 7
Modulating Cas9 activity for precision gene editing
Uslu, M., Si̇yah, P., Harvey, A. J., & Kocabaş, F. (2021) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2021.01.015 · Cited by 7
A Review: Computational Approaches to Design sgRNA of CRISPR-Cas9
Nasir, M. A., Nawaz, S., & Huang, J. H. (2021) · Current Bioinformatics · doi:10.2174/1574893616666210601105553 · Cited by 7
Systematic HIV-1 promoter targeting with CRISPR/dCas9-VPR reveals optimal region for activation of the latent provirus
Klinnert, S., Chemnitzer, A., Rusert, P., & Metzner, K. J. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001754 · Cited by 7
Single- and duplex TaqMan-quantitative PCR for determining the copy numbers of integrated selection markers during site-specific mutagenesis in Toxoplasma gondii by CRISPR-Cas9
Hänggeli, K. P. A., Hemphill, A. F., Müller, N., Schimanski, B., Olias, P., Müller, J., & Boubaker, G. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271011 · Cited by 7
ANIMAL ENGINEERING FOR XENOTRANSPLANTATION
Galli, C. (2023) · European Journal of Transplantation · doi:10.57603/ejt-307 · Cited by 7
CRISPR off-target analysis platforms
Xu, C. L., Ruan, M. Z., Ragi, S. D., & Tsang, S. H. (2023) · Methods in molecular biology · doi:10.1007/978-1-0716-2651-1_26 · Cited by 6
The CRISPR-dCas9 interference system suppresses inhA gene expression in Mycobacterium smegmatis
Singpanomchai, N., & Ratthawongjirakul, P. (2024) · Scientific Reports · doi:10.1038/s41598-024-77442-2 · Cited by 6
Strategies for plant-virus disease management from gene editing to nanotechnology
Chaturvedi, A., & Ranjan, R. (2025) · Physiology and Molecular Biology of Plants · doi:10.1007/s12298-025-01611-4 · Cited by 6
Precision Medicine in Neurodegenerative Diseases: Genomic Approaches to Target Amyloid-β, Tau, and Alpha-Synuclein Pathways
Waqar, Z., Sethi, P., Jain, D., Singh, K., Alsaidan, O. A., Alzarea, S. I., Gupta, J. K., Saxena, S., & Sharma, M. C. (2025) · Current Genomics · doi:10.2174/0113892029372437251010114053 · Cited by 6
scCausalVI disentangles single-cell perturbation responses with causality-aware generative model
An, S., Cho, J.-W., Cao, K., Xiong, J., Hemberg, M., & Wan, L. (2025) · Cell Systems · doi:10.1016/j.cels.2025.101443 · Cited by 7
CRISPR Genome Editing in Personalized Therapy for Oral and Maxillofacial Diseases: A Scoping Review
Dziedzic, A. M., Kubina, R., Skonieczna, M., Madej, M., Fiegler-Rudol, J., Abid, M. F., Nadhim, D., & Tanasiewicz, M. (2025) · Biomedicines · doi:10.3390/biomedicines13112745 · Cited by 6
Improved CRISPR/Cas9 off-target prediction with DNABERT and epigenetic features
Kimata, K., & Satou, K. (2025) · PLoS ONE · doi:10.1371/journal.pone.0335863 · Cited by 6
CRISPR Technology: Transforming the Future of Medicine and Diagnostics
Iyer, K. A., Tenchov, R., Diaz, L. M. L., Jain, P., Thite, T., Deng, Y., & Zhou, Q. A. (2025) · Biochemistry · doi:10.1021/acs.biochem.5c00480 · Cited by 9

Authors: Zhang, X.-H., Tee, L. Y., Wang, X.-G., Huang, Q.-S., & Yang, S.-H.
Affiliations: McGovern Institute for Brain Research (US)
ORCID: Tee, Louis Y
Venue: Molecular Therapy - Nucleic Acids
Publisher: Elsevier BV
Published: 2015
Volume: 4
Pages: e264
ISSN: 2162-2531 (ISSN-L)
DOI: 10.1038/mtna.2015.37
PMC: PMC4877446
OpenAlex: W2173737475
Cited by: 1,273
References: 82
Citations by year: 2026: 67 · 2025: 145 · 2024: 166 · 2023: 151 · 2022: 164 · 2021: 198 · 2020: 132 · 2019: 109 · 2018: 80 · 2017: 35 · 2016: 25 · 2015: 1
FWCI: 4.55
Type: journal article
Language: en
Open access: gold
doi.org
Licence: cc-by-nc-sa
www.elsevier.com/tdm/userlicense/1.0/ (tdm)
creativecommons.org/licenses/by-nc-sa/4.0/ (vor, 645 d)
Locations: Molecular Therapy — Nucleic Acids (publishedVersion, cc-by-nc-sa)
Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
PubMed Central (publishedVersion, cc-by-nc-sa)
PubMed (publishedVersion)
DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics: Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › CRISPR and Genetic Engineering
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA regulation and disease
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
Keywords: CRISPR/Cas9, off-target effects, genome editing, RNA-guided endonuclease, genome editing specificity, therapeutic genome editing

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Off-target Effects in CRISPR/Cas9-mediated Genome Engineering

Abstract

Overview

Integrity signals

Figures

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks